Friday, 10 April 2020

French Study of 1,500+ Patients Including Seniors See 98% Success Rate with Hydroxychloroquine-Azithromycin Regimen

French Study of 1,500+ Patients Including Seniors See 98% Success Rate with Hydroxychloroquine-Azithromycin Regimen



In late March FOX News host Laura Ingraham reported on the latest study by the French research team led by the renowned epidemiologist Dr. Didier Raoult was able to repeat his findings from a previous study.

This time Dr. Raoult administered hydroxychloroquine and azithromycin to 80 patients and observed improvement in EVERY CASE except for a very sick 86-year-old with an advanced form of coronavirus infection.


This is wonderful news.
Unfortunately, this doctor’s work helps the the global community and Trump so the the liberal media has either ignored, attacked or mocked his research.
What awful people.


Nos deux articles publiés ce soir permettent de contiuer à démontrer :
1. L'efficacité de notre protocole, sur 80 patients.
2. La pertinence de l'association de l'hydroxychloroquine et de l'azithromycine, grâce à des recherches réalisées dans notre laboratoire de confinement P3. https://twitter.com/raoult_didier/status/1243619270581465089 

8,926 people are talking about this
Nouvel article publié on-line par mes équipes : démonstration in vitro de la synergie hydroxychloroquine/azithromycine pour contrer la réplication du SARS-COV2

In vitro testing of Hydroxychloroquine and Azithromycin on SARS-CoV-2 shows synergistic effecthttps://www.mediterranee-infection.com/wp-content/uploads/2020/03/La-Scola-et-al-V1.pdf 
3,577 people are talking about this

Since that time Dr. Roult has continued his study and now has over 1,000 coronavirus patients.

98% of his COVID-19 patients have survived and improved using the drug combination.


No comments:

Post a Comment

Leave your thoughts & comments